Skip to content

A study to learn how different amounts of the study medicine called PF-07941944 are tolerated in the body of healthy adults.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515421-28-00
Acronym
C5961001
Enrollment
66
Registered
2024-11-27
Start date
2024-11-28
Completion date
2025-06-19
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RSV (Respiratory Syncytial Virus)

Interventions

None listed

Sponsors

Pfizer Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026